Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia

John P. Houston, James W. Maas, Charles L. Bowden, Salvador A. Contreras, Kathryn L. McIntyre, Martin A. Javors

Resultado de la investigación: Articlerevisión exhaustiva

30 Citas (Scopus)

Resumen

In 16 patients with chronic schizophrenia, cerebrospinal fluid (CSF) concentrations of homovanillic acid (HVA) showed a significant negative correlation with computed tomographic measures of brain third ventricle size. Clinical state during a drug-free period was also significantly correlated with CSF HVA level, but not with third ventricle size when the effect of CSF HVA was partialed out. The authors propose that these findings may reflect an atrophic process involving structures around the third ventricle and a decrease in dopaminergic activity.

Idioma originalEnglish (US)
Páginas (desde-hasta)207-214
Número de páginas8
PublicaciónPsychiatry Research
Volumen19
N.º3
DOI
EstadoPublished - nov 1986

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Huella

Profundice en los temas de investigación de 'Cerebrospinal fluid HVA, central brain atrophy, and clinical state in schizophrenia'. En conjunto forman una huella única.

Citar esto